Jaroslaw Bilinski | Principal Chief Executive Officer
Human Biome Institute

Jaroslaw Bilinski, Principal Chief Executive Officer, Human Biome Institute

Physician, scientist, innovator, entrepreneur and academic teacher at the Medical University of Warsaw, accomplished specialization in hematology at the Department of Hematology, Transplantation and Internal Medicine University Clinical Center of the Medical University of Warsaw. Founder and CEO of Human Biome Institute – being his research commercialization. Former vice president of the Regional Medical Council in Warsaw. During medical studies, he was a laureate of many competitions and a Scholarship from the Minister of Science and Higher Education. In 2013 he graduated from the Faculty of Medicine with the highest score of the year at the Collegium Medicum in Bydgoszcz of the Nicolaus Copernicus University in Toruń. He graduated a year before the plan of doctoral studies at the Medical University of Warsaw, and in 2017 he defended his doctoral dissertation with distinction at the First Medical Faculty of the Medical University of Warsaw. Winner of the prestigious Award of the 5th Faculty of Medicine of the Polish Academy of Sciences. In 2020, he was the winner of the prestigious polish “Golden OTIS” competition in the “scientific debut of the year” category. Also, in 2020, elected as a “Young Ambassador” of the European Society for Blood and Marrow Transplantation (EBMT). In his research work, he deals with topics in the fields of hematology, clinical transplantology, immunology, metagenomics, genetics and cancer response, gut microbiome and its interactions with the host. Author of many full-text publications in prestigious scientific journals, conference summaries and conference reports, including at prestigious international congresses. Impact Factor >200, Hirsch index 12, Number of citations >800. Leader of 7 research grants (over 3 million euros in total), co-researcher in the international clinical trials, including study within the framework of the European Society for Blood and Marrow Transplantation (EBMT). As a scientist and Human Biome CEO created a full spectrum microbiome company, with up to date, and new, revolutionary deep-tech solutions to create first in the world synthetic, autonomous, donor-independent microbiome drugs. Human Biome flagship project is to create Anti-Antibiotic Resistant Bacteria, Anti-antibiotic-resistnat Infections New Generation Biotherapeutic, which changes the AMR crisis and brings people lower risk of being infected.

Appearances:



Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:40

Presentation: Future breakthrough therapy in the prevention of AMR infections - A synthetic, autonomous, AI-chosen microbiome based biotherapeutic. Human Biome's journey to make it real

last published: 12/Jun/24 19:45 GMT
last published: 12/Jun/24 19:45 GMT

back to speakers


GET INVOLVED AT THE

WORLD ANTIMICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


Justin Franks

justin.franks@terrapinn.com
+1 914 819 3506

 

To Speak


Kaylee Nguyen

kaylee.nguyen@terrapinn.com

 

 

Press & Media Partnerships

 


Kaylie Brogan

kaylie.brogan@terrapinn.com

 

 

Start-Ups & Posters

 


Semen Sen

semen.sen@terrapinn.com
+1 646.619.1793